activistcompany
Van Herk Investments sent a letter to the Board of ProQR Therapeutics (PRQR)
Key Summary: On May 23, 2025, Van Herk Investments B.V., holding over 10% of ProQR, opposes the reappointments of
activistcompany
Profile of companies that are targetted by activists
activistcompany
Gary Gelbfish, M.D. Appointed as Observer to the CorMedix’ Board of Directors by Elliott Management
Key Summary: On June 27, 2017, Elliott Associates announced that Dr. Gary Gelbfish has been appointed as a Board Observer
activistcompany
Galloway Urges Strategic Review to Address Undervaluation at Global Crossing Airlines Group (JETBF)
Key Summary: Galloway Capital Partners (4.33%) sent a letter urging the company to explore strategic options—including a sale,
activistcompany
Garden Investment Management entered into a Cooperation Agreement with Middleby Corp (MIDD)
Key Summary: On February 24, 2025, Garden Investment Management entered into a Cooperation Agreement with the company. Pursuant to the
activistcompany
JBS S.A. Shareholders Approve Dual Listing on NYSE and B3
Key Summary: On May 15, 2025, Mason Capital Management (2.4%) urged SEC to investigate ISS and Glass Lewis over
activistcompany
Theofilos and MAZ Partners plan to seek Board, Management changes at electroCore, Inc (ECOR)
Key Summary: On May 14, 2025, Charles S. Theofilos (6%) and MAZ Partners (1.8%) said they are evaluating changes
activistcompany
Wynnefield Partners entered into a cooperation agreement with Quest Resource Holding Corp (QRHC)
Key Summary: On May 7, 2025, the company entered into a cooperation agreement with Wynnefield Partners
Market Cap: $51 million|
activistcompany
BML Capital Urges AN2 Therapeutics, Inc. (ANTX) to Liquidate After Drug Failure
Key Summary: On May 7, 2025, BML Capital (19.1%) urged AN2’s Board to sell or liquidate the company
activistcompany
13D weekly report - Apr 28, 2025 to May 02, 2025
Table of content
Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead
Key Summary: On April 29, 2025, Trium
activistcompany
Starboard Highlights Salesforce's (CRM)Operational Gains and Future Potential
Key Summary: On October 20, 2024, Starboard highlighted Salesforce Inc.'s significant improvements in operating margins and profitability in
activistcompany
Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead
Key Summary: On April 29, 2025, Trium Capital opposes the Acelyrin-Alumis merger, citing undervaluation, flawed process, ignored alternatives, and conflicts
activistcompany
Galloway Capital Partners Considering Legal Action Against Weight Watchers International, Inc. (WW)
Key Summary: On April 25, 2025, Galloway Capital Partners (2.87%) opposed the company’s rumored Chapter 11, citing strong
activistcompany
Outerbridge Capital reaches agreement with Barnes & Noble Education (BNED)
Key Summary: From June 2020 to June 2022, Outerbridge Capital engaged with the company via cooperation agreements—starting with board
activistcompany
VBF LP Withdraws Activism Following Perion Network Ltd (PERI) Governance Concession
Key Summary: On April 21, 2025, Value Base Ltd (5.85%) opposed the Board's adoption of a Poison
activistcompany
Engine Capital Withdraws Board Slate Following $750M Buyback Commitment by Lyft (LYFT)
Key Summary: On April 16, 2025, Engine Capital, owning ~1%, nominated Alan L. Bazaar and Daniel B. Silvers for election
activistcompany
Woodbridge Nominates Two Directors to Replace Retiring Thomson Reuters (TRI) Board Member
Key Summary: On April 16, 2025, Woodbridge nominated Michael Friisdahl and Paul Sagan to replace retiring director W. Edmund Clark
activistcompany
BML Capital Calls for Liquidation and Cash Return at Elevation Oncology (ELEV)
Key Summary: On April 16, 2025, BML Capital Management sent a letter to the Board expressing its belief that an
activistcompany
BML Investment Partners Urges ESSA Pharma (EPIX) to Liquidate and Return Cash to Shareholders
Key Summary: On April 15, 2025, Soleus Capital (5.1%) urged ESSA Pharma to wind down operations and return cash